CTC
AGN

Central Trust Company’s Allergan plc AGN Stock Holding History

Central Trust Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,516
Closed -$1.33M – 1193
2020
Q1 		$1.33M Sell
7,516
-524
-7% -$98.7K 0.08% 186
2019
Q4 		$1.54M Sell
8,040
-723
-8% -$130K 0.08% 197
2019
Q3 		$1.48M Sell
8,763
-270
-3% -$44K 0.08% 194
2019
Q2 		$1.5M Sell
9,033
-1,039
-10% -$144K 0.09% 192
2019
Q1 		$1.48M Sell
10,072
-1,656
-14% -$240K 0.09% 192
2018
Q4 		$1.57M Sell
11,728
-2,737
-19% -$449K 0.1% 176
2018
Q3 		$2.76M Buy
14,465
+4
+0% +$735 0.16% 134
2018
Q2 		$2.41M Sell
14,461
-539
-4% -$86.5K 0.15% 142
2018
Q1 		$2.52M Sell
15,000
-2,929
-16% -$491K 0.16% 136
2017
Q4 		$2.93M Sell
17,929
-9,368
-34% -$1.68M 0.18% 119
2017
Q3 		$5.59M Buy
27,297
+331
+1% +$77K 0.36% 69
2017
Q2 		$6.55M Buy
26,966
+351
+1% +$82.5K 0.43% 63
2017
Q1 		$6.36M Buy
26,615
+6,884
+35% +$1.6M 0.42% 62
2016
Q4 		$4.14M Sell
19,731
-21,108
-52% -$4.37M 0.29% 95
2016
Q3 		$9.41M Buy
40,839
+7,624
+23% +$1.86M 0.69% 36
2016
Q2 		$7.67M Buy
33,215
+2,806
+9% +$647K 0.57% 42
2016
Q1 		$8.15M Buy
30,409
+2,080
+7% +$595K 0.64% 36
2015
Q4 		$8.85M Buy
28,329
+1,356
+5% +$404K 0.73% 34
2015
Q3 		$7.33M Buy
26,973
+972
+4% +$299K 0.64% 38
2015
Q2 		$7.89M Buy
26,001
+3,265
+14% +$974K 0.62% 38
2015
Q1 		$6.77M Buy
22,736
+8,516
+60% +$2.43M 0.54% 46
2014
Q4 		$3.66M Buy
14,220
+7,380
+108% +$1.84M 0.3% 85
2014
Q3 		$1.65M Buy
6,840
+1,450
+27% +$325K 0.13% 153
2014
Q2 		$1.2M Buy
5,390
+4,500
+506% +$932K 0.09% 194
2014
Q1 		$183K Sell
890
-265
-23% -$52.5K 0.02% 431
2013
Q4 		$194K Hold
1,155
– – 0.02% 425
2013
Q3 		$166K Sell
1,155
-160
-12% -$21.3K 0.02% 430
2013
Q2 		$166K Buy
+1,315
New +$149K 0.02% 409

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Central Trust Company's AGN Position: Q2 2020 in Review

Central Trust Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,516 shares — an estimated $1.33M sold.

Central Trust Company first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $9.41M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Central Trust Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Central Trust Company sold 7,516 Allergan plc shares in Q2 2020, an estimated $1.33M.
  • Central Trust Company first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Central Trust Company's Allergan plc position peaked at $9.41M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Central Trust Company's 13F filing for Q2 2020, filed 14 Jul 2020.